Aldeyra Therapeutics, Inc.
ALDXNASDAQHealthcare● Active
$1.74
+$0.11(+6.75%)
Market Cap$104958658
P/E Ratio—
52W High$6.175
52W Low$1.07
Aldeyra Therapeutics, Inc. (ALDX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ALDX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.07B | $0.10B | $0.14B | $0.17B | $0.23B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.07B | $0.10B | $0.15B | $0.18B | $0.23B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.07B | $0.10B | $0.15B | $0.18B | $0.23B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.00B | $0.02B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.03B | $0.02B | $0.02B | $0.02B | $0.01B |
| Long-Term Debt | $0.00B | $0.01B | $0.00B | $0.01B | $0.02B |
| Total Liabilities | $0.03B | $0.03B | $0.03B | $0.03B | $0.03B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.48B) | ($0.45B) | ($0.39B) | ($0.36B) | ($0.29B) |
| Total Stockholders Equity | $0.04B | $0.07B | $0.12B | $0.15B | $0.21B |
| Total Liab & Equity(computed) | $0.07B | $0.10B | $0.15B | $0.18B | $0.23B |
| Debt Summary | |||||
| Total Debt | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| Net Debt | ($0.05B) | ($0.04B) | ($0.13B) | ($0.13B) | ($0.21B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Aldeyra Therapeutics, Inc. data
About Aldeyra Therapeutics, Inc. (ALDX) Balance Sheet
Aldeyra Therapeutics, Inc. (ALDX) balance sheet shows total assets of $0.07B with cash of $0.07B. Total liabilities are $0.03B, total debt $0.02B, and stockholders equity $0.04B.
Frequently asked questions
ALDX · 4 questionsAldeyra Therapeutics, Inc. has total debt of $0.02B with net debt of ($0.05B).
ALDX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10